心血管

订阅

MedSci主页 / 所有栏目 / 心血管

2009APSS建议——卒中二级预防发布

2016-07-25 阿尔伯塔省卒中策略(APSS,Alberta Provincial Stroke Strategy) APSS官网

卒中二级预防
关注

2009年2月，阿尔伯塔省卒中策略(APSS,Alberta Provincial Stroke Strategy))公布了卒中二级预防建议，主要为卒中二级预防服务提供指南，为临床管理提供最佳实践指导。获取全文：下载地址：指南下载(需要扣积分2分, 梅斯医学APP免积分下载)

2009年2月，阿尔伯塔省卒中策略(APSS,Alberta Provincial Stroke Strategy))公布了卒中二级预防建议，主要为卒中二级预防服务提供指南，为临床管理提供最佳实践指导。


获取全文：

下载地址：指南下载(需要扣积分2分, 梅斯医学APP免积分下载)

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=135097, encodeId=129713509e03, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:18:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482812, encodeId=18d91482812c0, content=<a href='/topic/show?id=f91e2694e8' target=_blank style='color:#2F92EE;'>#APS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2694, encryptionId=f91e2694e8, topicName=APS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Jul 27 00:47:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94730, encodeId=254794e30b0, content=可以学习了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Tue Jul 26 13:46:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94609, encodeId=d49c9460909, content=我也了解下，?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e1e1928298, createdName=吾, createdTime=Mon Jul 25 15:39:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94575, encodeId=0fbc945e55d, content=了解一下！, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 12:05:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-09-25 1e10c84am36(暂无匿称)

    文章很好值得关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=135097, encodeId=129713509e03, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:18:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482812, encodeId=18d91482812c0, content=<a href='/topic/show?id=f91e2694e8' target=_blank style='color:#2F92EE;'>#APS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2694, encryptionId=f91e2694e8, topicName=APS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Jul 27 00:47:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94730, encodeId=254794e30b0, content=可以学习了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Tue Jul 26 13:46:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94609, encodeId=d49c9460909, content=我也了解下，?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e1e1928298, createdName=吾, createdTime=Mon Jul 25 15:39:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94575, encodeId=0fbc945e55d, content=了解一下！, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 12:05:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-27 仁心济世

    #APS#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=135097, encodeId=129713509e03, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:18:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482812, encodeId=18d91482812c0, content=<a href='/topic/show?id=f91e2694e8' target=_blank style='color:#2F92EE;'>#APS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2694, encryptionId=f91e2694e8, topicName=APS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Jul 27 00:47:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94730, encodeId=254794e30b0, content=可以学习了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Tue Jul 26 13:46:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94609, encodeId=d49c9460909, content=我也了解下，?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e1e1928298, createdName=吾, createdTime=Mon Jul 25 15:39:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94575, encodeId=0fbc945e55d, content=了解一下！, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 12:05:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-26 JBY

    可以学习了解下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=135097, encodeId=129713509e03, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:18:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482812, encodeId=18d91482812c0, content=<a href='/topic/show?id=f91e2694e8' target=_blank style='color:#2F92EE;'>#APS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2694, encryptionId=f91e2694e8, topicName=APS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Jul 27 00:47:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94730, encodeId=254794e30b0, content=可以学习了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Tue Jul 26 13:46:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94609, encodeId=d49c9460909, content=我也了解下，?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e1e1928298, createdName=吾, createdTime=Mon Jul 25 15:39:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94575, encodeId=0fbc945e55d, content=了解一下！, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 12:05:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-25 吾

    我也了解下，?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=135097, encodeId=129713509e03, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:18:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482812, encodeId=18d91482812c0, content=<a href='/topic/show?id=f91e2694e8' target=_blank style='color:#2F92EE;'>#APS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2694, encryptionId=f91e2694e8, topicName=APS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Jul 27 00:47:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94730, encodeId=254794e30b0, content=可以学习了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Tue Jul 26 13:46:00 CST 2016, time=2016-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94609, encodeId=d49c9460909, content=我也了解下，?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e1e1928298, createdName=吾, createdTime=Mon Jul 25 15:39:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94575, encodeId=0fbc945e55d, content=了解一下！, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 25 12:05:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-25 1dd8c52fm63(暂无匿称)

    了解一下！

    0

相关资讯

Stroke：介入治疗大血管闭塞性卒中是有效的（独立于静脉溶栓）

背景：在过去的十年，紧急大血管闭塞的血管内介入治疗（ELVO）发展迅速。是否静脉溶栓（IVT）预处理对ELVO患者功能预后有显著的影响仍不清楚。方法:研究对所有评估血管内治疗（ET）对急性缺血性卒中的疗效的随机对照试验，进行了系统的综述和荟萃分析。研究者按照IVT预治疗进行分层，进行的混合效应亚组分析报告，对ET（与标准治疗）与3功能结果的相关性的OR值。结果:纳入六项随机对照试验，包括1916

Stroke：收缩压与血管性痴呆的风险呈正相关

背景：血管性痴呆是第二大常见痴呆形式，但血压（BP）和血管性痴呆发生的风险特定年龄的相关性的可靠证据是有限的，一些研究报告在年龄较大的负面联想。方法:从电子初级保健健康档案（英国临床实践研究数据库）中识别无已知的心血管疾病和老年痴呆症428万人。研究者将BP和诊断血管性痴呆的时间联系起来。研究者在短暂性脑缺血发作和卒中（牛津血管研究）中进行潜在性的记录，探讨血压和老年痴呆症之间的关联。结果:随访时

吸烟增加民众出现蛛网膜下腔出血风险

蛛网膜下腔出血(SAH)是出血性脑血管病的一个类型，分原发性和继发性两种。 原发性蛛网膜下腔出血是由于脑表面和脑底的血管破裂出血，血液直接流入蛛网膜下腔所致。蛛网膜下腔出血是神经科最常见的急症之一,属于卒中的一种表现类型，会导致严重并发症的出现，如瘫痪、昏迷和死亡。 在情绪激动、体力劳动、咳嗽、用力排便、饮酒、性交等情况下突发性剧烈头痛是蛛网膜下腔出血的主要症状,少数患者发病前有头痛、头晕、视力改

JAHA：年轻人要警惕卒中和TIA

背景：研究报告称，年轻成人缺血性脑卒中的发病率高于50岁至55岁的成年人。对其他亚型的卒中和短暂性脑缺血发作（TIA）的时间趋势信息是不足的。本研究的目的是探讨年龄15岁至30岁TIA和卒中住院率的变化趋势，包括性别和亚型特异性趋势。方法和结果：从丹麦国家病人登记记录中，研究者确定在丹麦所有1994-2012年住院的首次卒中和TIA患者（年龄15-30岁）。采用泊松回归估计估计年度百分比变化率（E

Stroke：临床量表不能准确识别大动脉闭塞性卒中

背景：临床评分是否可以帮助识别急性大动脉闭塞的缺血性卒中患者，改善治疗的分类是有争议的。研究者旨在确定公布的临床评分预测大动脉闭塞的准确性。方法:研究者评估了13个临床评分预测急性缺血性脑卒中患者大动脉闭塞的性能，这些患者发病6小时内进行临床检查和磁共振或CT血管造影。当无界值点时，研究者使用界值最大化的增加研究队列敏感性和特异性的总和。研究者还决定，对每一个评分，一个假阴性率≤10%与界值点相关

Neurology：新治疗的癫痫患者死亡率和住院发病率升高

目的：评估新治疗癫痫的住院发病率和死亡率。方法:研究者从涵盖所有香港的公立医院的数据库中，提取了2005年9月16日到2010年9月15日之间，新治疗癫痫患者的相关数据。随访患者至2011年9月15日。对基线并发症，抗癫痫药物（AEDs）的使用，以及酶诱导的抗癫痫药物（EIAEDS）进行分层，评估住院死亡率和发病率。比较香港人群中年龄和性别特异性的死亡率。结果:7461个新治疗的癫痫患者（55%名